Common genetic variation and breast cancer Risk—Past, present, and future

Research output: Contribution to journalEditorial

15 Citations (Scopus)

Abstract

Breast cancer is the most common cancer among women in the United States, with up to 30% of those diagnosed displaying a family history of breast cancer. To date, 18% of the familial risk of breast cancer can be explained by SNPs. This review summarizes the discovery of risk-associated SNPs using candidate gene and genome-wide association studies (GWAS), including discovery and replication in large collaborative efforts such as The Collaborative Oncologic Gene-environment Study and OncoArray. We discuss the evolution of GWAS studies, efforts to discover additional SNPs, and methods for identifying causal variants. We summarize findings associated with overall breast cancer, patho-logic subtypes, and mutation carriers (BRCA1, BRCA2, and CHEK2). In addition, we summarize the development of polygenic risk scores (PRS) using the risk-associated SNPs and show how PRS can contribute to estimation of individual risks for developing breast cancer.

Original languageEnglish (US)
Pages (from-to)380-394
Number of pages15
JournalCancer Epidemiology Biomarkers and Prevention
Volume27
Issue number4
DOIs
StatePublished - Apr 1 2018

Fingerprint

Breast Neoplasms
Single Nucleotide Polymorphism
Genome-Wide Association Study
Genes
Mutation
Neoplasms

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Common genetic variation and breast cancer Risk—Past, present, and future. / Lilyquist, Jenna; Ruddy, Kathryn J; Vachon, Celine M; Couch, Fergus J.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 27, No. 4, 01.04.2018, p. 380-394.

Research output: Contribution to journalEditorial

@article{464288d97ea04cf1943210e08eaa09f6,
title = "Common genetic variation and breast cancer Risk—Past, present, and future",
abstract = "Breast cancer is the most common cancer among women in the United States, with up to 30{\%} of those diagnosed displaying a family history of breast cancer. To date, 18{\%} of the familial risk of breast cancer can be explained by SNPs. This review summarizes the discovery of risk-associated SNPs using candidate gene and genome-wide association studies (GWAS), including discovery and replication in large collaborative efforts such as The Collaborative Oncologic Gene-environment Study and OncoArray. We discuss the evolution of GWAS studies, efforts to discover additional SNPs, and methods for identifying causal variants. We summarize findings associated with overall breast cancer, patho-logic subtypes, and mutation carriers (BRCA1, BRCA2, and CHEK2). In addition, we summarize the development of polygenic risk scores (PRS) using the risk-associated SNPs and show how PRS can contribute to estimation of individual risks for developing breast cancer.",
author = "Jenna Lilyquist and Ruddy, {Kathryn J} and Vachon, {Celine M} and Couch, {Fergus J}",
year = "2018",
month = "4",
day = "1",
doi = "10.1158/1055-9965.EPI-17-1144",
language = "English (US)",
volume = "27",
pages = "380--394",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "4",

}

TY - JOUR

T1 - Common genetic variation and breast cancer Risk—Past, present, and future

AU - Lilyquist, Jenna

AU - Ruddy, Kathryn J

AU - Vachon, Celine M

AU - Couch, Fergus J

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Breast cancer is the most common cancer among women in the United States, with up to 30% of those diagnosed displaying a family history of breast cancer. To date, 18% of the familial risk of breast cancer can be explained by SNPs. This review summarizes the discovery of risk-associated SNPs using candidate gene and genome-wide association studies (GWAS), including discovery and replication in large collaborative efforts such as The Collaborative Oncologic Gene-environment Study and OncoArray. We discuss the evolution of GWAS studies, efforts to discover additional SNPs, and methods for identifying causal variants. We summarize findings associated with overall breast cancer, patho-logic subtypes, and mutation carriers (BRCA1, BRCA2, and CHEK2). In addition, we summarize the development of polygenic risk scores (PRS) using the risk-associated SNPs and show how PRS can contribute to estimation of individual risks for developing breast cancer.

AB - Breast cancer is the most common cancer among women in the United States, with up to 30% of those diagnosed displaying a family history of breast cancer. To date, 18% of the familial risk of breast cancer can be explained by SNPs. This review summarizes the discovery of risk-associated SNPs using candidate gene and genome-wide association studies (GWAS), including discovery and replication in large collaborative efforts such as The Collaborative Oncologic Gene-environment Study and OncoArray. We discuss the evolution of GWAS studies, efforts to discover additional SNPs, and methods for identifying causal variants. We summarize findings associated with overall breast cancer, patho-logic subtypes, and mutation carriers (BRCA1, BRCA2, and CHEK2). In addition, we summarize the development of polygenic risk scores (PRS) using the risk-associated SNPs and show how PRS can contribute to estimation of individual risks for developing breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=85045519018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045519018&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-17-1144

DO - 10.1158/1055-9965.EPI-17-1144

M3 - Editorial

C2 - 29382703

AN - SCOPUS:85045519018

VL - 27

SP - 380

EP - 394

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 4

ER -